Walder L - Search Results

1

Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective.

Liu J, Hawkes C, Walder L, Spalding C, Travers K, Maiese EM, Hurteau J. Liu J, et al. Among authors: walder l. J Manag Care Spec Pharm. 2021 Oct;27(10):1377-1387. doi: 10.18553/jmcp.2021.27.10.1377. J Manag Care Spec Pharm. 2021. PMID: 34595950 Free PMC article.

2

Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States.

Guy H, Walder L, Fisher M. Guy H, et al. Among authors: walder l. Pharmacoeconomics. 2019 Mar;37(3):391-405. doi: 10.1007/s40273-018-0745-z. Pharmacoeconomics. 2019. PMID: 30478649 Free PMC article.

3

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.

Matulonis UA, Walder L, Nøttrup TJ, Bessette P, Mahner S, Gil-Martin M, Kalbacher E, Ledermann JA, Wenham RM, Woie K, Lau S, Marmé F, Casado Herraez A, Hardy-Bessard AC, Banerjee S, Lindahl G, Benigno B, Buscema J, Travers K, Guy H, Mirza MR. Matulonis UA, et al. Among authors: walder l. J Clin Oncol. 2019 Dec 1;37(34):3183-3191. doi: 10.1200/JCO.19.00917. Epub 2019 Sep 16. J Clin Oncol. 2019. PMID: 31518175 Free PMC article.

4

Systematic literature review of efficacy and safety of first-line maintenance therapy trials in advanced ovarian cancer.

Guy H, Hawkes C, Walder L, Malinowska IA, Gupta D. Guy H, et al. Among authors: walder l. Future Oncol. 2022 Sep;18(30):3435-3447. doi: 10.2217/fon-2022-0578. Epub 2022 Sep 14. Future Oncol. 2022. PMID: 36102225 Review.

5

Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective.

Lubinga SJ, Walder L, Burton M, Shen Q. Lubinga SJ, et al. Among authors: walder l. J Med Econ. 2024 Jan-Dec;27(1):1212-1221. doi: 10.1080/13696998.2024.2403278. Epub 2024 Sep 24. J Med Econ. 2024. PMID: 39254489 Free article.

6

Response to 'Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"'.

Guy H, Walder L, Fisher M. Guy H, et al. Among authors: walder l. Pharmacoeconomics. 2019 Jul;37(7):965-967. doi: 10.1007/s40273-019-00803-7. Pharmacoeconomics. 2019. PMID: 31044349 No abstract available.

7

Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective.

Coleman RL, Lubinga SJ, Shen Q, Walder L, Burton M, Mathews C. Coleman RL, et al. Among authors: walder l. Gynecol Oncol. 2024 Nov 8;192:24-31. doi: 10.1016/j.ygyno.2024.10.021. Online ahead of print. Gynecol Oncol. 2024. PMID: 39520771

8

Reduced versus standard dose contrast volume for contrast-enhanced abdominal CT in overweight and obese patients using photon counting detector technology vs. second-generation dual-source energy integrating detector CT.

Hagen F, Estler A, Hofmann J, Walder L, Faby S, Almarie B, Nikolaou K, Wrazidlo R, Horger M. Hagen F, et al. Among authors: walder l. Eur J Radiol. 2023 Dec;169:111153. doi: 10.1016/j.ejrad.2023.111153. Epub 2023 Oct 18. Eur J Radiol. 2023. PMID: 38250749

9

Effects of different virtual monoenergetic CT image data on chest wall post-processing "unfolded ribs" and proposal of an algorithm improvement.

Hagen F, Grimmer R, Ditt H, Walder L, Wrazidlo R, Karolin B, Hofmann J, Estler A, Horger M. Hagen F, et al. Among authors: walder l. Int J Comput Assist Radiol Surg. 2023 Feb;18(2):339-351. doi: 10.1007/s11548-022-02721-0. Epub 2022 Aug 13. Int J Comput Assist Radiol Surg. 2023. PMID: 35962904

10

Radiation Dose Reduction in Contrast-Enhanced Abdominal CT: Comparison of Photon-Counting Detector CT with 2nd Generation Dual-Source Dual-Energy CT in an oncologic cohort.

Wrazidlo R, Walder L, Estler A, Gutjahr R, Schmidt B, Faby S, Fritz J, Nikolaou K, Horger M, Hagen F. Wrazidlo R, et al. Among authors: walder l. Acad Radiol. 2023 May;30(5):855-862. doi: 10.1016/j.acra.2022.05.021. Epub 2022 Jun 24. Acad Radiol. 2023. PMID: 35760710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters